The Advanced Research Projects Agency for Health announced on September 9, 2026, the teams receiving contract awards under its Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE) program, naming Atman Health among the performers selected to build a patient-facing clinical AI agent for heart failure patients. Atman’s award record lists an award of up to $7.7 million. Atman Health announced its selection the same day, stating that it will develop an agentic artificial intelligence…